Related Experiment Video
Updated: Aug 6, 2026

Testing Acetylcholine Followed by Adenosine for Invasive Diagnosis of Coronary Vasomotor Disorders
Published on: February 3, 2021
Guidelines for the management of patients with chronic stable angina: diagnosis and risk stratification
S V Williams1, S D Fihn, R J Gibbons
1Division of General Internal Medicine, 1220 Blockley Hall, 423 Guardian Drive, Philadelphia, PA 19104-6021, USA. sankey@wharton.upenn.edu
Insights
This guide outlines a three-stage evaluation for suspected chronic stable angina. It details diagnostic steps, including stress tests and cardiac catheterization, to assess coronary artery disease (CAD) risk and guide treatment.
Area of Science:
- Cardiology
- Diagnostic Imaging
- Clinical Medicine
Background:
- Chronic stable angina requires a structured diagnostic approach.
- Accurate risk stratification is crucial for managing coronary artery disease (CAD).
Framework:
- A three-stage evaluation process is proposed for suspected chronic stable angina.
- Stage one involves initial risk assessment using history, physical exam, labs, and ECG.
- Stage two employs stress testing (ECG, imaging) based on initial CAD probability.
- Stage three utilizes advanced imaging or angiography for risk-guided management.
Implementation:
- Exercise electrocardiography is the initial stress test for most new-onset angina patients.
- Stress imaging is recommended for specific ECG abnormalities or prior revascularization.
- Pharmacologic stress agents are used for patients unable to exercise.
- Coronary angiography is indicated for high-risk patients or those with left ventricular dysfunction.
Implications:
- This staged approach optimizes diagnostic accuracy for coronary artery disease.
- Risk stratification guides decisions on further testing and revascularization strategies.
- Tailored management based on risk improves patient outcomes in chronic stable angina.
Abstract:
Patients with suspected chronic stable angina can be evaluated in three stages. In stage one, the clinician uses information from the history, physical examination, laboratory tests for diabetes and hyperlipidemia, and resting electrocardiography to estimate the patient's probability of coronary artery disease (CAD). In stage two, additional testing for patients with a low probability of CAD focuses on diagnosing noncoronary causes of chest pain. Patients with a high probability of CAD have stress tests to assess their risk from CAD, and patients with an intermediate probability of CAD have stress tests to estimate the probability of CAD and assess their risk from CAD. Most patients with new-onset angina can start stress testing with exercise electrocardiography. The initial stress test should be a stress imaging procedure for patients with rest ST-segment depression greater than 1 mm, complete left bundle-branch block, ventricular paced rhythm, preexcitation syndrome, or previous revascularization with percutaneous coronary angioplasty or coronary artery bypass grafting. Patients who cannot exercise can have an imaging procedure with stress induced by pharmacologic agents. In stage three, patients with a predicted average annual cardiac mortality rate between 1% and 3% should have a stress imaging study or coronary angiography with left ventriculography. Those with a known left ventricular dysfunction should have cardiac catheterization. Patients with CAD who have an estimated annual mortality rate greater than 3% should have cardiac catheterization to determine whether their anatomy is suitable for revascularization. Patients with an estimated annual mortality rate less than 1% can begin to receive medical therapy.
Related Concept Videos
Acute Coronary Syndrome V: Nursing Management
Angina II: Classification
Angina III: Clinical Manifestations and Assessment
Angina IV: Management
Angina V: Nursing Management
Atherosclerosis III: Management

